berberine has been researched along with thromboplastin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhmedov, A; Holy, EW; Lüscher, TF; Tanner, FC | 1 |
| Jiang, W; Kou, J; Sun, L; Yu, B; Yuan, S | 1 |
| Chen, L; Gao, MY; Kou, JP; Yang, L; Yu, BY; Yu, X | 1 |
3 other study(ies) available for berberine and thromboplastin
| Article | Year |
|---|---|
Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells.
Topics: Animals; Aorta; Berberine; Cell Line; Epithelial Cells; Humans; Hypolipidemic Agents; JNK Mitogen-Activated Protein Kinases; Lipoproteins; Male; Mice; Phosphorylation; Polymerase Chain Reaction; Promoter Regions, Genetic; RNA Stability; Simvastatin; Thromboplastin; Tumor Necrosis Factor-alpha | 2009 |
A simplified and high-throughput chromogenic assay for testing tissue factor-dependent procoagulant activity.
Topics: Berberine; Blood Coagulation Factors; Cells, Cultured; Chromogenic Compounds; Curcumin; Drug Evaluation, Preclinical; Endothelial Cells; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Lipoproteins; Simvastatin; Thromboplastin; Tumor Necrosis Factor-alpha | 2011 |
Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-κB/p65, Akt and MAPK pathway in THP-1 cells.
Topics: Berberine; Cell Line, Tumor; Down-Regulation; Humans; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction; Thromboplastin | 2014 |